Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Senti Biosciences Holdings, Inc. (SNTI) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Senti Biosciences Holdings, Inc. (SNTI), most recent 12 months reported: revenue $22K, net loss $49.56M, free cash flow -$43.64M. Latest balance sheet on file: liquid cash $6.46M, total debt $3.99M, net cash $2.47M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): aTYR PHARMA INC · VivoSim Labs, Inc. · AIM ImmunoTech Inc. · INMUNE BIO INC. · Creative Medical Technology Holdings, Inc. · Acumen Pharmaceuticals, Inc. · Abpro Holdings, Inc. · AGENTIX CORP.

Stock screener

Watchlist